태양광 차단 기능성 물질 스크리닝 방법 및 태양광 차단 효능 평가 방법
    101.
    发明公开
    태양광 차단 기능성 물질 스크리닝 방법 및 태양광 차단 효능 평가 방법 审中-实审
    太阳能保护功能材料的筛选方法及评估阳光保护效果的方法

    公开(公告)号:KR1020150064573A

    公开(公告)日:2015-06-11

    申请号:KR1020130149424

    申请日:2013-12-03

    CPC classification number: C12Q1/6883 C12N15/11 C12Q2600/158

    Abstract: 본발명의태양광차단기능측정방법에따르면, 태양광조사에따른피부세포내 유전자발현량을비교함으로써정확하고객관적으로태양광차단기능성물질스크리닝하거나, 태양광차단효능을평가할수 있다. 또한, 본발명에따른방법은케라틴 10(Keratin 10), 케라틴 1(Keratin 1), 필라그린(Filaggrin) 및트랜스글루타미나아제 3(Transglutaminase 3)를이용함으로써가시광선중 가장피부손상을가장많이유도하는 400∼500 nm 파장의블루/바이올렛라이트의차단여부까지판별할수 있으므로, 보다세분화된태양광차단기능측정결과를제공할수 있다.

    Abstract translation: 根据本发明,用于测量阳光保护功能的方法可以精确地屏蔽阳光保护功能材料,并且可以通过根据阳光的照射比较皮肤细胞中的基因表达比来评估阳光保护的效果。 此外,该方法可以区分是否阻挡400-500nm波长的蓝色/紫色光,通过使用角蛋白10,角蛋白1,丝聚蛋白和转谷氨酰胺酶3,最多可以诱发可见光线中的皮肤损伤,从而提供亚专利结果 测量阳光保护功能。

    피부의 볼륨 증가 촉진용 조성물
    102.
    发明公开
    피부의 볼륨 증가 촉진용 조성물 无效
    用于促进皮肤体积的组合物

    公开(公告)号:KR1020140097095A

    公开(公告)日:2014-08-06

    申请号:KR1020140092563

    申请日:2014-07-22

    CPC classification number: A61K36/49 A61K8/97 A61K36/537 A61K36/898 A61Q19/08

    Abstract: The present invention relates to a composition for promoting the differentiation of human mesenchymal stem cells into adipocytes. More specifically, the present invention relates to a composition for cosmetics or plastic surgery which increases the sense of volume of specific body part by creating lipid droplets by comprising at least one species among Castaneae semen, Selaginella tamariscina, Aloe vera, Salvia miltiorrhiza, Mentha arvensis, Pinellia ternate, Triticum aestivum, Saururus chinensis, Polygala tenuifolia, and Gleditsia sinensis extracts as an active ingredient to promote the differentiation of human mesenchymal stem cells into adipocytes.

    Abstract translation: 本发明涉及促进人间充质干细胞向脂肪细胞分化的组合物。 更具体地说,本发明涉及一种用于化妆品或整容手术的组合物,其通过在蓖麻精,卷柏,芦荟,丹参中提取至少一种物质,通过产生脂滴来增加特定身体部位的体积感 ,Pinellia ternate,Triticum aestivum,Saururus chinensis,Polygala tenuifolia和Gleditsia sinensis提取物作为活性成分,促进人类间充质干细胞分化成脂肪细胞。

    지방대사 이상질환의 치료 및 예방용 약학 조성물

    公开(公告)号:KR101349185B1

    公开(公告)日:2014-01-16

    申请号:KR1020060121960

    申请日:2006-12-05

    Abstract: 본 발명은 지방대사 이상질환의 치료 및 예방용 약학 조성물에 관한 것으로, 화학식 1의 화합물을 유효성분으로 포함하는 본 발명의 약학 조성물은 인간 간세포에서 생체내 에너지 대사에 중요한 역할을 하는 아이소싸이트레이트 탈수소효소 3α (IDH3α) 프로모터와 카르니틴 팔미토일 트랜스퍼레이즈 1A (CPT1A) 프로모터의 활성을 증가시켜, 혈당 및 중성지방의 감소 및 결과적으로 체중의 감소를 가져오므로, 비만, 고지혈증, 당뇨병 등의 지방대사 이상질환의 예방 및 치료에 유용하게 사용될 수 있다.

    피부 색소 침착 조절물질을 스크리닝하는 방법
    106.
    发明公开
    피부 색소 침착 조절물질을 스크리닝하는 방법 审中-实审
    用于调节皮肤颜色的材料的筛选方法

    公开(公告)号:KR1020130051353A

    公开(公告)日:2013-05-20

    申请号:KR1020110116647

    申请日:2011-11-09

    Abstract: PURPOSE: A method for screening a material which regulates skin pigmentation is provided to screen a material for regulating skin pigmentation, and to effectively treat hyperpigmentation or hypopigmentation by regulating intracellular and intercellular signal transduction faction and transcription factor. CONSTITUTION: A method for screening a material which regulates skin pigmentation comprises: a step of treating one or more gene selected from the group consisting of IFN gamma, IL4, IL17, IL6, STAT3, STAT6, JAK1, JAK2, and JAK3 with a candidate material; and a step of selecting a candidate material which enhances or reduces gene expression as a material which regulates skin pigmentation. A candidate material which enhances gene expression is selected as a useful material which possibly suppresses pigmentation. A candidate material which reduces gene expression is selected as a useful material which possibly enhances skin pigmentation. [Reference numerals] (AA) Comparative example; (BB) Example 1; (CC) Example 2; (DD) Example 3

    Abstract translation: 目的:提供一种筛选调节皮肤色素沉着的材料的方法,筛选调节皮肤色素沉着的材料,并通过调节细胞内和细胞间信号转导系和转录因子有效治疗色素沉着过度或色素沉着不足。 构成:筛选调节皮肤色素沉着的材料的方法包括:用候选物质治疗选自IFNγ,IL4,IL17,IL6,STAT3,STAT6,JAK1,JAK2和JAK3的一种或多种基因的步骤 材料; 以及选择增强或降低基因表达作为调节皮肤色素沉着的材料的候选物质的步骤。 选择增强基因表达的候选物质作为可能抑制色素沉着的有用材料。 选择减少基因表达的候选物质作为可能增强皮肤色素沉着的有用材料。 (附图标记)(AA)比较例; (BB)实施例1; (CC)实施例2; (DD)实施例3

    인간 중간엽줄기세포의 분화 촉진용 조성물
    108.
    发明公开
    인간 중간엽줄기세포의 분화 촉진용 조성물 无效
    促进人类间质干细胞分化的组合物

    公开(公告)号:KR1020120092754A

    公开(公告)日:2012-08-22

    申请号:KR1020110001219

    申请日:2011-01-06

    Inventor: 신동욱 노민수

    Abstract: PURPOSE: A composition for promoting differentiation from human mesenchymal stem cells into adipocytes is provided to enhance skin volume and elasticity ad to improve anti-wrinkling. CONSTITUTION: An external use skin composition for promoting adipocyte differentiation contains 0.0001-30 wt% of Chrysanthemi sibirici Herba extract as an active ingredient. The composition promotes the differentiation of human mesenchymal stem cells into adipocytes. A pharmaceutical composition for promoting adipocyte differentiation contains the extract as an active ingredient. The daily dose of the extract is 0.001mg/kg/day-2000mg/kg/day.

    Abstract translation: 目的:提供用于促进从人间充质干细胞分化成脂肪细胞的组合物,以增强皮肤体积和弹性,以改善抗皱纹。 构成:用于促进脂肪细胞分化的外用皮肤组合物含有0.0001-30重量%的菊花西布提取物作为活性成分。 该组合物促进人间充质干细胞分化为脂肪细胞。 用于促进脂肪细胞分化的药物组合物含有提取物作为活性成分。 提取物的日剂量为0.001mg / kg /天-2000mg / kg /天。

    선스크린용 조성물
    110.
    发明公开
    선스크린용 조성물 有权
    SUNSCREEN的组合物

    公开(公告)号:KR1020120058688A

    公开(公告)日:2012-06-08

    申请号:KR1020100116411

    申请日:2010-11-22

    Abstract: PURPOSE: A composition containing cinnamic acid derivatives, methoxy phenyl acrylate derivatives, and beta,beta-diphenylacrylate derivatives is provided to improve photo stability. CONSTITUTION: A composition for sun screening contains cinnamic acid derivatives, methoxy phenyl acrylate derivatives, and beta-beta-diphenyl acrylate derivatives as an active ingredient. The methoxy phenyl acrylate derivative is ethyl hexyl methoxy crylene. The beta-beta-diphenyl acrylate derivative includes octocrylene, etocrylene, or both. The composition further contains triazine derivatives, salicylic acid derivatives, and benzalmalonate derivatives.

    Abstract translation: 目的:提供含有肉桂酸衍生物,甲氧基苯基丙烯酸酯衍生物和β,β-二苯基丙烯酸酯衍生物的组合物以改善光稳定性。 构成:防晒组合物含有肉桂酸衍生物,甲氧基苯基丙烯酸酯衍生物和作为活性成分的β-β-二苯基丙烯酸酯衍生物。 甲氧基苯基丙烯酸酯衍生物是乙基己基甲氧基二烯丙基。 β-β-二苯基丙烯酸酯衍生物包括辛烯丙烯,乙酰亚甲基或二者。 组合物还含有三嗪衍生物,水杨酸衍生物和亚苄基丙二酸酯衍生物。

Patent Agency Ranking